Mr Manish Gupta, CEO, Indegene
Indegene offers scientific partnership to global life science companies by delivering a spectrum of medical, marketing, training, intelligence, and analytics services. Mr Manish Gupta, CEO, Indegene has more than 15 years of experience. He has pioneered the application of robust and scalable operational processes to the domain of pharmaceutical commercialization and scientific services. At Indegene, he is responsible for general operations, investor relations, and driving the overall strategy of the company.
Excerpts of the interview.
With respect to Indian context, how potent do you think is social media in pharma companies? How can social media analytics help in understanding the market dynamics for the Indian industry?
A recent COMSCORE report places India as the fastest growing online market amongst Brazil, Russia, India and China (BRIC) nations, and has a 10 percent penetration rate. The health sector has experienced 43 percent YOY growth over the last 12 months, positioning both users and the healthcare industry as prominent users of internet-based information and networking. Since patients are already widely using the internet to search for information, pharma companies have realized the need to understand sentiments and be present where their customers are already active.
Social media in pharma is very different from how one may use popular social networking sites, as there is significant risk and compliance that must be ensured to effectively engage stakeholders. We, at Indegene have a tremendous applied understanding of how this needs to be done from experience, conceptualizing to building and implementing client programs across market places, including India.